| Lung-function trajectories leading to chronic obstructive pulmonary disease P Lange, B Celli, A Agustí, G Boje Jensen, M Divo, R Faner, S Guerra, ... New England Journal of Medicine 373 (2), 111-122, 2015 | 1401 | 2015 |
| Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? DMG Halpin, R Faner, O Sibila, JR Badia, A Agusti The Lancet Respiratory Medicine 8 (5), 436-438, 2020 | 454 | 2020 |
| Lung function in early adulthood and health in later life: a transgenerational cohort analysis A Agustí, G Noell, J Brugada, R Faner The lancet Respiratory medicine 5 (12), 935-945, 2017 | 346 | 2017 |
| Lung function trajectories in health and disease A Agusti, R Faner The Lancet Respiratory Medicine 7 (4), 358-364, 2019 | 314 | 2019 |
| Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis R Faner, M Rojas, W MacNee, A Agustí American journal of respiratory and critical care medicine 186 (4), 306-313, 2012 | 301 | 2012 |
| The microbiome in respiratory medicine: current challenges and future perspectives R Faner, O Sibila, A Agustí, E Bernasconi, JD Chalmers, GB Huffnagle, ... European Respiratory Journal 49 (4), 2017 | 268 | 2017 |
| Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan A Agustí, E Melén, DL DeMeo, R Breyer-Kohansal, R Faner The lancet Respiratory medicine 10 (5), 512-524, 2022 | 242 | 2022 |
| Lessons from ECLIPSE: a review of COPD biomarkers R Faner, R Tal-Singer, JH Riley, B Celli, J Vestbo, W MacNee, P Bakke, ... Thorax 69 (7), 666-672, 2014 | 205 | 2014 |
| Precision medicine in airway diseases: moving to clinical practice A Agustí, M Bafadhel, R Beasley, EH Bel, R Faner, PG Gibson, R Louis, ... European Respiratory Journal 50 (4), 2017 | 201 | 2017 |
| COPD 2020: changes and challenges A Agustí, C Vogelmeier, R Faner American Journal of Physiology-Lung Cellular and Molecular Physiology 319 (5 …, 2020 | 159 | 2020 |
| Systemic inflammation and comorbidities in chronic obstructive pulmonary disease A Agustí, R Faner Proceedings of the American Thoracic Society 9 (2), 43-46, 2012 | 136 | 2012 |
| Network analysis of lung transcriptomics reveals a distinct B-cell signature in emphysema R Faner, T Cruz, T Casserras, A López-Giraldo, G Noell, I Coca, ... American journal of respiratory and critical care medicine 193 (11), 1242-1253, 2016 | 134 | 2016 |
| What does endotyping mean for treatment in chronic obstructive pulmonary disease? A Agustí, B Celli, R Faner The Lancet 390 (10098), 980-987, 2017 | 117 | 2017 |
| Treatment trials in young patients with chronic obstructive pulmonary disease and pre–chronic obstructive pulmonary disease patients: time to move forward FJ Martinez, A Agusti, BR Celli, MLK Han, JP Allinson, SP Bhatt, ... American journal of respiratory and critical care medicine 205 (3), 275-287, 2022 | 114 | 2022 |
| Inhaled steroids, circulating eosinophils, chronic airway infection, and pneumonia risk in chronic obstructive pulmonary disease. A network analysis MA Martinez-Garcia, R Faner, G Oscullo, D de La Rosa, ... American journal of respiratory and critical care medicine 201 (9), 1078-1085, 2020 | 113 | 2020 |
| Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype BR Celli, N Locantore, R Tal-Singer, J Riley, B Miller, J Vestbo, JC Yates, ... European Respiratory Journal 51 (2), 2018 | 107 | 2018 |
| Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance R Colobran, MP Armengol, R Faner, M Gärtner, LO Tykocinski, A Lucas, ... Human molecular genetics 20 (17), 3415-3423, 2011 | 105 | 2011 |
| Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014 A Agustí, JM Antó, C Auffray, F Barbé, E Barreiro, J Dorca, J Escarrabill, ... American journal of respiratory and critical care medicine 191 (4), 391-401, 2015 | 91 | 2015 |
| Network medicine, multimorbidity and the lung in the elderly R Faner, T Cruz, A López-Giraldo, A Agustí European Respiratory Journal 44 (3), 775-788, 2014 | 87 | 2014 |
| Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study SC Dharmage, DS Bui, EH Walters, AJ Lowe, B Thompson, G Bowatte, ... The Lancet Respiratory Medicine 11 (3), 273-282, 2023 | 83 | 2023 |
Alvar AgustiUniversitat de Barcelona, Institut Respiratori, Hospital Clínic, IDIBAPS,CIBER EnfermedadesVerified email at clinic.ub.es